Robert Mohr, MD
Obstetrics & Gynecology · Randolph, NJNPI 1205919065
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.2%), speaking fees and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Celularity Inc. at 48.5% of the total. Reporting peaked in 2022 at $1,766 and has fallen 90.9% since, to $160 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $27.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$3K
- Mayne Pharma Commercial LLC$425
- AbbVie$385
- Merck$193
- Millicent US Inc$182
- Pfizer$167
- plus $2K from 24 others
What the payments were for
- Speaking & faculty fees$2,70048%
- Food & beverage$2,80150%
- Education$821%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 9 | $2,710 |
| Mayne Pharma Commercial LLC | 31 | $425 |
| AbbVie(2 entities) | 32 | $385 |
| Merck | 13 | $193 |
| Millicent US Inc | 13 | $182 |
| Pfizer | 11 | $167 |
| Therapeuticsmd, Inc. | 11 | $167 |
| Myovant Sciences Inc. | 10 | $155 |
| Exeltis, USA Inc. | 11 | $155 |
| Exact Sciences | 6 | $141 |
| Amgen | 7 | $102 |
| Evofem Biosciences, Inc. | 6 | $85 |
| Davol Inc. | 2 | $75 |
| Biohaven Pharmaceuticals, Inc. | 5 | $70 |
| Sumitomo Pharma America, Inc. | 4 | $66 |
| Organon | 3 | $61 |
| Agile Therapeutics, Inc. | 4 | $60 |
| Avion Pharmaceuticals | 4 | $58 |
| Astellas Pharma US Inc | 3 | $56 |
| Bayer | 2 | $49 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $41 |
| Roche Diagnostics Corporation | 2 | $34 |
| Vertical Pharmaceuticals, LLC | 2 | $30 |
| AMAG Pharmaceuticals, Inc. | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Novum Pharma, LLC | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $14 |
| Ascend Therapeutics US, LLC | 1 | $14 |
| Dysis Medical, Inc. | 1 | $11 |
How this compares
$5,583 in reported general payments places this provider in the 90th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 21 | $11,371 |
| Estradiol | 62 | $6,445 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 18 | $350 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 36 | $349 |
| Sertraline Hcl | 23 | $294 |
| ProgesteroneProgesterone, Micronized | 11 | $278 |
| Zolpidem Tartrate | 24 | $256 |
| Fluconazole | 22 | $79 |
| Alprazolam | 18 | $57 |
| Azithromycin | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $167 | $11,37121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Other obstetrics & gynecology in Randolph
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
- Susan PitmanWest Orange$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.